Sana Biotechnology, Inc.

SANA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$3.18+1.60%

2026-08-03

Financials

Valuation Metrics

Sana Biotechnology, Inc.'s Market Cap is $885M. At end of 2025 it was $1.03B. Ranked #2563 of 3,112 in US market (top 82%), #1067 of 1,445 on NASDAQ (top 74%), #198 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 74%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$885M	US#2,563/3,112 Sec#198/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-242M	US—/3,112 Sec—/269
Total Assets	$374M	US#2,845/3,112 Sec#190/269
Net Assets	$119M	US#2,857/3,112 Sec#220/269
Value
P/B	7.42x	US#2,449/3,112 Sec#180/269
FCF Yield	-15.10%	US—/3,112 Sec—/269
Profitability
ROA	-64.77%	US#3,016/3,112 Sec#245/269
Financial Health
Debt Ratio	213.31%	US#1,857/3,112 Sec#204/269
Total Debt	$75M	US#2,450/3,112 Sec#131/269
FCF	$-134M	US#2,653/3,112 Sec#179/269
Cash	$84M	US#2,318/3,112 Sec#188/269
Current Ratio	1.29x	US#1,877/3,112 Sec#252/269
Performance
1Y Return	-18.67%	US#2,663/3,112 Sec#222/269
1M Return	-20.70%	US#2,957/3,112 Sec#236/269
From 52W High	-51.45%	US#2,810/3,112 Sec#222/269
1Y MDD	-54.73%	US#2,565/3,112 Sec#200/269
Trading
Volume	2,449,878 shares	US#751/3,112 Sec#67/269
Trading Value	$8M	US#2,483/3,112 Sec#201/269
Per Share
EPS	$-0.96	US—/3,112 Sec—/269
BPS	$0.64	US#2,667/3,112 Sec#215/269